Technical Analysis for SLN - Silence Therapeutics Plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 6.93 | -0.57% | -0.04 |
SLN closed down 0.57 percent on Wednesday, November 20, 2024, on 7.39 times normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 10% | about 22 hours ago |
| 10x Volume Pace | about 22 hours ago |
| Down 5% | about 22 hours ago |
| Down 3% | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Molecular Biology Gene Expression Genome RNA Rna Interference Molecular Genetics Nucleic Acids Gene Silencing Small Interfering Rna
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Molecular Biology Gene Expression Genome RNA Rna Interference Molecular Genetics Nucleic Acids Gene Silencing Small Interfering Rna
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.72 |
| 52 Week Low | 5.81 |
| Average Volume | 316,280 |
| 200-Day Moving Average | 20.05 |
| 50-Day Moving Average | 17.35 |
| 20-Day Moving Average | 15.69 |
| 10-Day Moving Average | 13.59 |
| Average True Range | 1.29 |
| RSI (14) | 7.41 |
| ADX | 31.59 |
| +DI | 6.03 |
| -DI | 59.71 |
| Chandelier Exit (Long, 3 ATRs) | 14.85 |
| Chandelier Exit (Short, 3 ATRs) | 9.68 |
| Upper Bollinger Bands | 22.66 |
| Lower Bollinger Band | 8.72 |
| Percent B (%b) | -0.13 |
| BandWidth | 88.86 |
| MACD Line | -2.29 |
| MACD Signal Line | -1.17 |
| MACD Histogram | -1.1247 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.05 | ||||
| Resistance 3 (R3) | 8.91 | 8.06 | 8.69 | ||
| Resistance 2 (R2) | 8.06 | 7.52 | 8.13 | 8.57 | |
| Resistance 1 (R1) | 7.50 | 7.19 | 7.08 | 7.64 | 8.46 |
| Pivot Point | 6.65 | 6.65 | 6.44 | 6.72 | 6.65 |
| Support 1 (S1) | 6.09 | 6.11 | 5.67 | 6.23 | 5.40 |
| Support 2 (S2) | 5.24 | 5.78 | 5.31 | 5.29 | |
| Support 3 (S3) | 4.68 | 5.24 | 5.17 | ||
| Support 4 (S4) | 4.82 |
